SCHEMBL8947142

SCHEMBL8947142

CC(C)c1nc(COC(=O)N[C@H](C(=O)NC(Cc2cncs2)CC(O)C(Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 20/20 0.81
CYP2D6 P10635 6/20 0.81
CYP2C19 P33261 3/20 0.81
CYP2C9 P11712 3/20 0.81
MEN1 O00255 1/20 0.81
SLC22A2 O15244 1/20 0.81
SLC22A1 O15245 1/20 0.81
ABCC3 O15438 1/20 0.81
ABCC4 O15439 1/20 0.81
MLNR O43193 1/20 0.81
NR1I2 O75469 1/20 0.81
SLCO2B1 O94956 1/20 0.81
ABCB11 O95342 1/20 0.81
ALDH1A1 P00352 1/20 0.81
PGR P06401 1/20 0.81
ABCB1 P08183 1/20 0.81
HTR1A P08908 1/20 0.81
ADRA2A P08913 1/20 0.81
ADORA3 P0DMS8 1/20 0.81
MAPT P10636 1/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7181349 1.00 CYP3A4 (0.81) CYP3A4CYP2D6CYP2C19CYP2C9MEN1
SCHEMBL7179463 0.98 CYP3A4 (0.85) CYP3A4CYP2D6CYP2C19CYP2C9MEN1
SCHEMBL7179449 0.97 CYP3A4 (0.77) CYP3A4CYP2D6CYP2C19CYP2C9MEN1
SCHEMBL7186272 0.95 CYP3A4 (0.80) CYP3A4CYP2D6CYP2C19CYP2C9MEN1
SCHEMBL7179293 0.92 CYP3A4 (0.81) CYP3A4CYP2D6CYP2C19CYP2C9MEN1
SCHEMBL7174097 0.92 CYP3A4 (0.96) CYP3A4CYP2D6CYP2C19CYP2C9MEN1
SCHEMBL7184080 0.92 CYP3A4 (0.82) CYP3A4CYP2D6CYP2C19CYP2C9MEN1
SCHEMBL28805838 0.91 CYP3A4 (0.76) CYP3A4CYP2D6CYP2C19CYP2C9MEN1
SCHEMBL7180295 0.91 CYP3A4 (0.76) CYP3A4CYP2D6CYP2C19CYP2C9MEN1
SCHEMBL7182301 0.90 CYP3A4 (0.80) CYP3A4CYP2D6CYP2C19CYP2C9MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5583233-A TREATING HUMAN IMMUNODEFICIENCY VIRUS INFECTIONS ABBOTT LABORATORIES (US) 1996-12-10 US disclosed